Literature DB >> 18210182

Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: prospective study.

Akiko Kawamata1, Masatoshi Iihara, Takahiro Okamoto, Takao Obara.   

Abstract

Osteoporosis is a major complication of Cushing's syndrome. The aim of the present study was to assess the chronologic effect of surgical cure on bone mineral density (BMD) in patients with Cushing's syndrome due to adrenal adenoma. BMD was examined in 28 patients before laparoscopic adrenalectomy; 17 patients with reduced BMD were then included in the longitudinal evaluation. BMD was determined using dual energy X-ray absorptiometry (DXA) before and at 3, 6, 12, 18, and 24 months after adrenalectomy. The prevalence of osteoporosis was 64% (95% confidence interval 44-81%). Preoperative BMD of the lumbar spine in the lateral projection was significantly lower than that of the femoral neck (mean+/-SD score: -3.53+/-0.75 vs. -1.54+/-0.22, p=0.003). A significant increase in BMD was observed at 3 months after surgery in the lumbar spine (p=0.0004). Improvement at both sites was maintained at 24 months after surgery. The postoperative percentage change in BMD of the lumbar spine was significantly higher than that of the femoral neck (mean+/-SD 36.7%+/-26.5% vs. 11.2%+/-12.1%, p=0.01). The change in the seven premenopausal patients was significantly higher than that in the three postmenopausal patients (p=0.0006). Surgical cure of hypercortisolism provides significant improvement in BMD in patients with Cushing's syndrome due to adrenal adenoma. The improvement is particularly apparent in the lumbar spine measured in the lateral projection. Premenopausal women are more likely to benefit from surgery in terms of secondary osteoporosis.

Entities:  

Mesh:

Year:  2008        PMID: 18210182     DOI: 10.1007/s00268-007-9394-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

Review 1.  Osteoporosis in Cushing's syndrome.

Authors:  Gregory Kaltsas; Luca Manetti; Ashley B Grossman
Journal:  Front Horm Res       Date:  2002       Impact factor: 2.606

2.  DEXA measurement of spine density in the lateral projection. I: Methodology.

Authors:  R B Mazess; C A Gifford; J P Bisek; H S Barden; J A Hanson
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

3.  Increased risk of osteoporotic fractures in patients with Cushing's syndrome.

Authors:  Peter Vestergaard; Jørgen Lindholm; Jens Otto L Jørgensen; Claus Hagen; Hans Christian Hoeck; Peter Laurberg; Lars Rejnmark; Kim Brixen; Lars Ø Kristensen; Ulla Feldt-Rasmussen; Leif Mosekilde
Journal:  Eur J Endocrinol       Date:  2002-01       Impact factor: 6.664

Review 4.  The science and therapy of glucocorticoid-induced bone loss.

Authors:  N E Lane; B Lukert
Journal:  Endocrinol Metab Clin North Am       Date:  1998-06       Impact factor: 4.741

Review 5.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

6.  Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome.

Authors:  K Godang; T Ueland; J Bollerslev
Journal:  Eur J Endocrinol       Date:  1999-08       Impact factor: 6.664

7.  Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.

Authors:  A R Hermus; A G Smals; L M Swinkels; D A Huysmans; G F Pieters; C F Sweep; F H Corstens; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

8.  Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases.

Authors:  P R Ebeling; J M Peterson; B L Riggs
Journal:  J Bone Miner Res       Date:  1992-11       Impact factor: 6.741

9.  Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma.

Authors:  Cristiano Maria Francucci; Paola Pantanetti; Gabriella Giuseppina Garrapa; Fernando Massi; Giorgio Arnaldi; Franco Mantero
Journal:  Clin Endocrinol (Oxf)       Date:  2002-11       Impact factor: 3.478

10.  Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.

Authors:  A Piovesan; M Terzolo; G Reimondo; A Pia; A Codegone; G Osella; A Boccuzzi; P Paccotti; A Angeli
Journal:  Horm Metab Res       Date:  1994-05       Impact factor: 2.936

View more
  11 in total

1.  Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines.

Authors:  Gherardo Mazziotti; Anna Maria Formenti; Robert A Adler; John P Bilezikian; Ashley Grossman; Emilia Sbardella; Salvatore Minisola; Andrea Giustina
Journal:  Endocrine       Date:  2016-10-20       Impact factor: 3.633

2.  Effects of Cushing disease on bone mineral density in a pediatric population.

Authors:  Maya B Lodish; Hui-Pin Hsiao; Anastasios Serbis; Ninet Sinaii; Anya Rothenbuhler; Margaret F Keil; Sosipatros A Boikos; James C Reynolds; Constantine A Stratakis
Journal:  J Pediatr       Date:  2010-03-10       Impact factor: 4.406

3.  Spontaneous recovery of bone mass after cure of endogenous hypercortisolism.

Authors:  Maria Elena Randazzo; Erika Grossrubatscher; Paolo Dalino Ciaramella; Angelo Vanzulli; Paola Loli
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

4.  Fracture risk assessment before and after resolution of endogenous hypercortisolism: is the FRAX® algorithm useful?

Authors:  Laura Trementino; Letizia Ceccoli; Carolina Concettoni; Giorgia Marcelli; Grazia Michetti; Marco Boscaro; Giorgio Arnaldi
Journal:  J Endocrinol Invest       Date:  2014-07-11       Impact factor: 4.256

5.  Osteoporosis: A Review of Treatment Options.

Authors:  Kristie N Tu; Janette D Lie; Chew King Victoria Wan; Madison Cameron; Alaina G Austel; Jenny K Nguyen; Kevin Van; Diana Hyun
Journal:  P T       Date:  2018-02

Review 6.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

7.  Known VDR polymorphisms are not associated with bone mineral density measures in pediatric Cushing disease.

Authors:  Maya B Lodish; Spyridon A Mastroyannis; Ninet Sinaii; Sosipatros A Boikos; Constantine A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

8.  Assessment of non-traumatic vertebral fractures in Cushing's syndrome patients.

Authors:  T Apaydın; D G Yavuz
Journal:  J Endocrinol Invest       Date:  2021-01-09       Impact factor: 4.256

Review 9.  Molecular Mechanisms and Emerging Therapeutics for Osteoporosis.

Authors:  Ji-Yoon Noh; Young Yang; Haiyoung Jung
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

10.  Mutiple Spontaneous Rib Fractures in Patient with Cushing's Syndrome.

Authors:  Hyun Jung Lee; Ji Hye Je; Ji Hye Seo; Young Ju Na; Hye Jin Yoo
Journal:  J Bone Metab       Date:  2014-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.